経皮吸収パッチの世界市場

経皮吸収パッチの世界市場は2030年までに100億米ドルに達する見込み

2024年に82億米ドルと推定される経皮吸収パッチの世界市場は、2024年から2030年にかけてCAGR 3.4％で成長し、2030年には100億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるリザーバー経皮吸収パッチは、CAGR 3.4％を記録し、分析期間終了時には36億米ドルに達すると予測されます。粘着剤入り医薬品（Drug-in-Adhesive経皮吸収パッチ）セグメントの成長率は、分析期間中CAGR 4.1％と推定されます。

米国市場は22億米ドル、中国はCAGR 6.3％で成長すると予測

米国の経皮吸収パッチ市場は、2024年に22億米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 6.3%で推移し、2030年までに20億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.4%と2.6%と予測されています。欧州では、ドイツがCAGR 1.9%で成長すると予測されています。

世界の経皮吸収パッチ市場- 主要動向と促進要因まとめ

なぜ経皮パッチがドラッグデリバリーの優先ルートになりつつあるのか？

経皮吸収パッチは、皮膚から血流に薬剤を安定的に送達する能力により、従来のドラッグデリバリー方法に代わる強力な選択肢として登場しました。このデリバリー・ルートは、侵襲的な注射や胃腸吸収の必要性をなくし、有効成分を長期間にわたってコントロールしながら放出することができます。当初はニコチン補充やホルモン療法用に開発されたが、経皮パッチの応用範囲は疼痛管理、神経疾患、心血管疾患、さらには避妊にまで大きく広がっています。主な魅力のひとつは患者のコンプライアンスで、パッチは使いやすく、投与回数が少なくて済み、経口剤や注射剤のような副作用が起こりにくいです。さらに、世界の高齢化と慢性疾患の増加に伴い、経皮吸収型パッチは、移動障害や認知障害のある患者にとって、便利でメンテナンスの少ない投薬方法を提供します。製薬企業はこのような利点を認識しており、浸透性とバイオアベイラビリティを高めるための新しいパッチ製剤、薬剤クラス別、材料の研究が加速しています。

材料科学と薬剤適合性はどのようにイノベーションを促進しているのか？

材料と製剤化学における最近の技術革新は、経皮パッチの性能と汎用性を著しく向上させています。ポリマー科学の進歩は、装着性と皮膚適合性を向上させる高性能接着剤、通気性バッキング、耐湿性膜の開発につながりました。さらに、皮膚に微細な経路を作るように設計されたマイクロニードルパッチは、ペプチド、ワクチン、インスリンなど、以前は適さなかった大きな分子の送達を可能にしています。これによって、生物製剤やバイオテクノロジー医薬品が経皮領域に参入する道が開かれました。イオントフォレーシスやエレクトロポレーション技術もまた、先進的なパッチに組み込まれつつあり、正確なコントロールで皮膚バリアを越えて薬剤を能動的に輸送することを可能にしています。さらに、放出制御型多層パッチやハイドロゲル・ベースのシステムも開発されており、投与タイミングや強度を管理することで、オーダーメイドの治療成果を提供しています。これらの技術革新は、治療可能な病態の幅を広げるだけでなく、旧世代の経皮吸収システムにおける長年の課題であった、皮膚刺激や投与量のばらつきのリスクを軽減しています。

個別化・遠隔ヘルスケアへのシフトがパッチの普及を後押し？

ヘルスケア提供の進化は、特にパンデミック後の時代において、在宅、患者中心、最小限の監視下での治療に重点を置いています。経皮吸収型テープ製剤は、こうした動向に完全に合致しており、病院中心の医療から分散型の個別化された投薬管理へのシフトを支えています。その使いやすさから、ヘルスケアへのアクセスが限られている遠隔地や地方の人々にとって理想的です。さらに、パッチはコネクテッド・ヘルス・システムに統合されつつあり、バイタル、薬物吸収、皮膚の状態をリアルタイムでモニターする「スマート・パッチ」が開発されています。センサーとBluetooth接続を備えたこれらのウェアラブル・ヘルステック・ソリューションは、患者と臨床医の双方への継続的なフィードバックを可能にすることで、慢性疾患管理に革命をもたらす態勢を整えています。さらに、デジタルヘルス企業と製薬会社は、アドヒアランス追跡、投与リマインダー、データロギング用のモバイルアプリとリンク可能なパッチベースのドラッグデリバリー・プラットフォームの開発に共同で取り組んでいます。このようなデジタル化により、経皮療法はより効果的であるだけでなく、よりインタラクティブで透明性の高いものとなり、健康志向の消費者やデータ主導型の医療提供者にとって魅力的なものとなっています。

世界経皮吸収パッチ市場の成長軌道を牽引しているのは？

経皮吸収パッチ市場の成長は、技術の進歩、治療モデルの進化、患者行動の変化と結びついたいくつかの要因によって牽引されています。主な成長要因の1つは、マイクロニードル技術、薬物溶解度工学、ポリマー製剤の画期的な進歩によって可能になった経皮適合薬のパイプラインの拡大です。さらに、非侵襲的な自己投与療法に対する需要の高まり（特に老人、小児、慢性疾患患者の間で）が、導入に拍車をかけています。また、高血圧、関節炎、ホルモン障害などのライフスタイルに関連した疾患の増加も、長時間持続し、メンテナンスの少ないドラッグデリバリー形態に対する持続的な需要を生み出しています。米国、EU、アジアにおけるウェアラブル医療機器に対する規制支援と迅速化された経路は、製薬会社による経皮製品ラインへの投資を促しています。さらに、遠隔ヘルスケア、遠隔医療、在宅治療レジメンの台頭は、全人的ケア計画の一環としてのパッチの関連性を強めています。最後に、研究開発投資の拡大とバイオテクノロジー企業と機器メーカー間の戦略的提携により、特に糖尿病、アルツハイマー病、オピオイド中毒など、送達に関する課題が未解決の疾患に対する新規経皮療法の商業化が加速しています。

セグメント

製品タイプ（リザーバー経皮吸収パッチ、Drug-in-Adhesive経皮吸収パッチ、マイクロニードル経皮吸収パッチ、マトリックス経皮吸収パッチ、その他経皮吸収パッチ）、販売タイプ（処方薬販売タイプ、市販薬販売タイプ）、流通チャネル（病院薬局流通チャネル、小売薬局流通チャネル、オンライン薬局流通チャネル）、アプリケーション（疼痛管理アプリケーション、ホルモン疾患アプリケーション、禁煙補助アプリケーション、神経疾患アプリケーション、循環器疾患アプリケーション、その他アプリケーション）

調査対象企業の例（注目の合計47社）

• AdhexPharma
• Besins Healthcare
• Cipla Ltd.
• Corium, Inc.
• Endo International plc
• GlaxoSmithKline plc
• Grunenthal GmbH
• Henan Lingrui Pharmaceutical Ltd
• Hisamitsu Pharmaceutical Co., Inc.
• Johnson & Johnson
• Luye Pharma Group Ltd.
• Medherant Ltd
• Mylan N.V.（now part of Viatris）
• Novartis AG
• Noven Pharmaceuticals, Inc.
• Purdue Pharma L.P.
• Samyang Biopharmaceuticals Corp.
• Teikoku Pharma USA, Inc.
• Teva Pharmaceutical Industries Ltd.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

無料アップデート弊社のお客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Transdermal Skin Patches Market to Reach US$10.0 Billion by 2030

The global market for Transdermal Skin Patches estimated at US$8.2 Billion in the year 2024, is expected to reach US$10.0 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2024-2030. Reservoir Transdermal Skin Patches, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth in the Drug-in-Adhesive Transdermal Skin Patches segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 6.3% CAGR

The Transdermal Skin Patches market in the U.S. is estimated at US$2.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.0 Billion by the year 2030 trailing a CAGR of 6.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 2.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Transdermal Skin Patches Market - Key Trends & Drivers Summarized

Why Are Transdermal Patches Becoming a Preferred Route for Drug Delivery?

Transdermal skin patches have emerged as a powerful alternative to traditional drug delivery methods due to their ability to deliver medication steadily through the skin into the bloodstream. This delivery route eliminates the need for invasive injections or gastrointestinal absorption, offering a controlled release of active ingredients over extended periods. Initially developed for nicotine replacement and hormone therapy, the application scope of transdermal patches has expanded significantly to include pain management, neurological disorders, cardiovascular disease, and even birth control. One of the key attractions is patient compliance-patches are easier to use, require less frequent dosing, and are less prone to the side effects that come with oral or injectable routes. Moreover, as the global population ages and chronic disease prevalence increases, transdermal patches provide a convenient, low-maintenance method of medication delivery for patients with mobility or cognitive impairments. Pharmaceutical companies are recognizing these advantages, leading to accelerated research into new patch formulations, drug classes, and materials for enhanced permeability and bioavailability.

How Is Material Science and Drug Compatibility Driving Innovation?

Recent innovations in materials and formulation chemistry are significantly enhancing the performance and versatility of transdermal patches. Advances in polymer science have led to the development of high-performance adhesives, breathable backings, and moisture-resistant membranes that improve wearability and skin compatibility. Furthermore, microneedle patches-designed to create microscopic pathways in the skin-are enabling delivery of larger, previously unsuitable molecules such as peptides, vaccines, and insulin. This has opened the door to biologics and biotech drugs entering the transdermal space. Iontophoresis and electroporation technologies are also being incorporated into advanced patches, enabling active transport of medications across the skin barrier with precise control. Additionally, controlled-release multilayer patches and hydrogel-based systems are being developed to manage dose timing and intensity, offering tailored therapeutic outcomes. These innovations are not only expanding the range of treatable conditions but are also reducing the risk of skin irritation and dosage inconsistency, long-standing challenges in earlier generations of transdermal systems.

Is the Shift Toward Personalized and Remote Healthcare Fueling Patch Adoption?

The evolution of healthcare delivery-especially in the post-pandemic era-is emphasizing home-based, patient-centric, and minimally supervised treatments. Transdermal patches align perfectly with these trends, supporting the shift away from hospital-centric care to decentralized, personalized medication management. Their ease of use makes them ideal for remote and rural populations, where healthcare access may be limited. Moreover, patches are being integrated into connected health systems, with “smart patches” now in development to monitor vitals, drug absorption, and skin condition in real time. These wearable health tech solutions, equipped with sensors and Bluetooth connectivity, are poised to revolutionize chronic disease management by enabling continuous feedback to both patients and clinicians. Additionally, digital health companies and pharmaceutical firms are collaborating to develop patch-based drug delivery platforms that can be linked to mobile apps for adherence tracking, dosage reminders, and data logging. This digitization is making transdermal therapy not only more effective but also more interactive and transparent-appealing to health-conscious consumers and data-driven providers alike.

What Is Driving the Growth Trajectory of the Global Transdermal Skin Patches Market?

The growth in the transdermal skin patches market is driven by several factors tied to technological advancement, evolving treatment models, and changing patient behavior. One of the primary growth drivers is the expanding pipeline of transdermal-compatible drugs enabled by breakthroughs in microneedle technology, drug solubility engineering, and polymer formulation. Additionally, rising demand for non-invasive, self-administered therapies-particularly among geriatric, pediatric, and chronic care patients-is fueling adoption. Increased incidences of lifestyle-related conditions such as hypertension, arthritis, and hormonal disorders are also creating sustained demand for long-duration, low-maintenance drug delivery formats. Regulatory support and expedited pathways for wearable medical devices in the U.S., EU, and Asia are encouraging pharmaceutical companies to invest in transdermal product lines. Furthermore, the rise of remote healthcare, telemedicine, and at-home treatment regimens is reinforcing the relevance of patches as part of holistic care plans. Lastly, growing R&D investments and strategic partnerships between biotech firms and device manufacturers are accelerating commercialization of novel transdermal therapies-especially for diseases with unmet delivery challenges, such as diabetes, Alzheimer’s, and opioid addiction.

SCOPE OF STUDY:

The report analyzes the Transdermal Skin Patches market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches, Other Transdermal Skin Patches); Sales Type (Prescription Sales Type, Over-the-Counter Sales Type); Distribution Channel (Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel); Application (Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

• AdhexPharma
• Besins Healthcare
• Cipla Ltd.
• Corium, Inc.
• Endo International plc
• GlaxoSmithKline plc
• Grunenthal GmbH
• Henan Lingrui Pharmaceutical Ltd
• Hisamitsu Pharmaceutical Co., Inc.
• Johnson & Johnson
• Luye Pharma Group Ltd.
• Medherant Ltd
• Mylan N.V. (now part of Viatris)
• Novartis AG
• Noven Pharmaceuticals, Inc.
• Purdue Pharma L.P.
• Samyang Biopharmaceuticals Corp.
• Teikoku Pharma USA, Inc.
• Teva Pharmaceutical Industries Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Transdermal Skin Patches - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Preference for Non-Invasive Drug Delivery Methods Spurs Adoption of Transdermal Patches
  • Expanding Use in Chronic Disease Management Drives Demand for Long-Acting Patches
  • Rising Incidence of Opioid Misuse Throws Spotlight on Pain-Free Alternative Delivery Systems
  • Advances in Drug Formulation Technologies Expand Range of Deliverable Compounds
  • Regulatory Approvals for Hormone and Nicotine Replacement Patches Sustain Market Confidence
  • Growth in Geriatric Population Propels Demand for Easy-to-Use Medication Formats
  • Direct-to-Consumer Sales Channels Boost Awareness and Accessibility
  • High Bioavailability and Controlled Release Capabilities Strengthen Clinical Appeal
  • Increasing Investment in Wearable Drug Delivery Devices Enhances R&D Activity
  • Expanding Veterinary and Pediatric Applications Generate New Revenue Streams
  • Reduced Side Effects Compared to Oral Medications Drives Patient Preference
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Transdermal Skin Patches Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Transdermal Skin Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Transdermal Skin Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Transdermal Skin Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Reservoir Transdermal Skin Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Reservoir Transdermal Skin Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Reservoir Transdermal Skin Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Drug-in-Adhesive Transdermal Skin Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Drug-in-Adhesive Transdermal Skin Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Drug-in-Adhesive Transdermal Skin Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Microneedle Transdermal Skin Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Microneedle Transdermal Skin Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Microneedle Transdermal Skin Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Matrix Transdermal Skin Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Matrix Transdermal Skin Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Matrix Transdermal Skin Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Transdermal Skin Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Transdermal Skin Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Transdermal Skin Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Online Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Online Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Online Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Hospital Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Retail Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Pain Management Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Pain Management Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Pain Management Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Hormonal Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Hormonal Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Hormonal Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Smoking Reduction & Cessation Aid Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Smoking Reduction & Cessation Aid Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Smoking Reduction & Cessation Aid Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Neurological Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Neurological Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Neurological Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Cardiovascular Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Cardiovascular Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Cardiovascular Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Prescription Sales Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Prescription Sales Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Prescription Sales Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Over-the-Counter Sales Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Over-the-Counter Sales Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: World 15-Year Perspective for Over-the-Counter Sales Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Transdermal Skin Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 53: USA Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 56: USA Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: USA 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 59: USA Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: USA Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: USA 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 62: USA Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: USA Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: USA 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Canada 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Canada 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 71: Canada Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Canada Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Canada 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 74: Canada Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Canada Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Canada 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• JAPAN
  • Transdermal Skin Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Japan 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Japan 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 83: Japan Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Japan Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Japan 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 86: Japan Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Japan Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Japan 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• CHINA
  • Transdermal Skin Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 89: China Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: China 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 92: China Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: China 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 95: China Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: China Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: China 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 98: China Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: China Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: China 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• EUROPE
  • Transdermal Skin Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Transdermal Skin Patches by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Transdermal Skin Patches by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for Transdermal Skin Patches by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Europe 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Europe 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 110: Europe Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Europe Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Europe 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 113: Europe Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Europe Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Europe 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• FRANCE
  • Transdermal Skin Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 116: France Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: France 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 119: France Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: France Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: France 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 122: France Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: France Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: France 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 125: France Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: France Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: France 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• GERMANY
  • Transdermal Skin Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Germany 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 131: Germany Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Germany Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Germany 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 134: Germany Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Germany Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Germany 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 137: Germany Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Germany Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Germany 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Italy 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 143: Italy Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Italy Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Italy 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 146: Italy Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Italy Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Italy 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 149: Italy Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Italy Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Italy 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Transdermal Skin Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 152: UK Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: UK 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 155: UK Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: UK Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: UK 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 158: UK Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: UK Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: UK 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 161: UK Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: UK Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: UK 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Spain 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 167: Spain Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Spain Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Spain 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 170: Spain Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Spain Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Spain 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 173: Spain Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Spain Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Spain 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Russia 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 179: Russia Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Russia Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Russia 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 182: Russia Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Russia Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Russia 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 185: Russia Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Russia Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Russia 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Europe 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Europe Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Europe 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Europe Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Europe 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Transdermal Skin Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Transdermal Skin Patches by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Transdermal Skin Patches by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 15-Year Perspective for Transdermal Skin Patches by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Asia-Pacific 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Asia-Pacific Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Asia-Pacific 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Asia-Pacific Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Asia-Pacific 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Transdermal Skin Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Australia 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 218: Australia Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Australia Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Australia 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 221: Australia Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Australia Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Australia 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 224: Australia Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Australia Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Australia 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• INDIA
  • Transdermal Skin Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 227: India Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: India 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 230: India Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: India Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: India 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 233: India Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: India Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: India 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 236: India Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: India Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: India 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: South Korea 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: South Korea Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: South Korea 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 245: South Korea Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: South Korea Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: South Korea 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 248: South Korea Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: South Korea Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: South Korea 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Rest of Asia-Pacific Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Rest of Asia-Pacific 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Rest of Asia-Pacific Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Rest of Asia-Pacific 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Transdermal Skin Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Transdermal Skin Patches by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Transdermal Skin Patches by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Latin America 15-Year Perspective for Transdermal Skin Patches by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Latin America 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Latin America Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Latin America 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 272: Latin America Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Latin America Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Latin America 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 275: Latin America Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Latin America Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Latin America 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Argentina 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Argentina Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Argentina 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 284: Argentina Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Argentina Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Argentina 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 287: Argentina Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Argentina Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Argentina 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Brazil 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Brazil Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Brazil 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 296: Brazil Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Brazil Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Brazil 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 299: Brazil Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Brazil Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Brazil 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Mexico 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Mexico Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Mexico 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 308: Mexico Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Mexico Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Mexico 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 311: Mexico Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Mexico Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Mexico 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Rest of Latin America 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Rest of Latin America Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Rest of Latin America 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Rest of Latin America Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Rest of Latin America 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Transdermal Skin Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Transdermal Skin Patches by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Transdermal Skin Patches by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Middle East 15-Year Perspective for Transdermal Skin Patches by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Middle East 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Middle East Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Middle East 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 335: Middle East Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Middle East Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Middle East 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 338: Middle East Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Middle East Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Middle East 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Iran 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 344: Iran Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Iran Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Iran 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 347: Iran Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Iran Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Iran 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 350: Iran Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Iran Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Iran 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Israel 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 356: Israel Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Israel Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Israel 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 359: Israel Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Israel Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Israel 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 362: Israel Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Israel Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Israel 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: Saudi Arabia 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Saudi Arabia Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: Saudi Arabia 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Saudi Arabia Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Saudi Arabia 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: UAE 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 380: UAE Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: UAE Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: UAE 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 383: UAE Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: UAE Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: UAE 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 386: UAE Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: UAE Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: UAE 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Rest of Middle East 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Rest of Middle East Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Rest of Middle East 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Rest of Middle East Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: Rest of Middle East 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030
• AFRICA
  • Transdermal Skin Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for Transdermal Skin Patches by Product Type - Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Africa 15-Year Perspective for Transdermal Skin Patches by Product Type - Percentage Breakdown of Value Sales for Reservoir Transdermal Skin Patches, Drug-in-Adhesive Transdermal Skin Patches, Microneedle Transdermal Skin Patches, Matrix Transdermal Skin Patches and Other Transdermal Skin Patches for the Years 2015, 2025 & 2030
  • TABLE 404: Africa Recent Past, Current & Future Analysis for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Africa Historic Review for Transdermal Skin Patches by Distribution Channel - Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 406: Africa 15-Year Perspective for Transdermal Skin Patches by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Retail Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 407: Africa Recent Past, Current & Future Analysis for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Africa Historic Review for Transdermal Skin Patches by Application - Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 409: Africa 15-Year Perspective for Transdermal Skin Patches by Application - Percentage Breakdown of Value Sales for Pain Management Application, Hormonal Disorders Application, Smoking Reduction & Cessation Aid Application, Neurological Disorders Application, Cardiovascular Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 410: Africa Recent Past, Current & Future Analysis for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Africa Historic Review for Transdermal Skin Patches by Sales Type - Prescription Sales Type and Over-the-Counter Sales Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 412: Africa 15-Year Perspective for Transdermal Skin Patches by Sales Type - Percentage Breakdown of Value Sales for Prescription Sales Type and Over-the-Counter Sales Type for the Years 2015, 2025 & 2030

IV. COMPETITION